INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 66 filers reported holding INFINITY PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 0.62 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $17,000 | -65.3% | 15,000 | -42.1% | 0.00% | 0.0% |
| Q2 2018 | $49,000 | -18.3% | 25,900 | -9.4% | 0.00% | 0.0% |
| Q1 2018 | $60,000 | -1.6% | 28,600 | -38.4% | 0.00% | 0.0% |
| Q3 2017 | $61,000 | -78.0% | 46,400 | -77.4% | 0.00% | -85.7% |
| Q4 2016 | $277,000 | +242.0% | 205,700 | +294.8% | 0.01% | +133.3% |
| Q3 2016 | $81,000 | -48.7% | 52,100 | +73.1% | 0.00% | -62.5% |
| Q1 2016 | $158,000 | +85.9% | 30,100 | +198.0% | 0.01% | +33.3% |
| Q3 2015 | $85,000 | -28.6% | 10,100 | -7.3% | 0.01% | -66.7% |
| Q2 2015 | $119,000 | -31.2% | 10,900 | -15.5% | 0.02% | -45.5% |
| Q3 2014 | $173,000 | – | 12,900 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 15,232,268 | $41,279,000 | 3.63% |
| NORTHPOINTE CAPITAL LLC | 528,739 | $1,433,000 | 0.21% |
| Opaleye Management Inc. | 275,000 | $745,000 | 0.19% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 364,401 | $988,000 | 0.12% |
| EcoR1 Capital, LLC | 462,068 | $1,252,000 | 0.11% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 990,748 | $2,685,000 | 0.08% |
| GSA CAPITAL PARTNERS LLP | 284,354 | $771,000 | 0.04% |
| Fosun International Ltd | 358,859 | $879,000 | 0.04% |
| Clear Harbor Asset Management, LLC | 97,630 | $200,000 | 0.04% |
| 180 WEALTH ADVISORS, LLC | 30,000 | $81,000 | 0.04% |